ArticleMolecular neurobiology2023

Dual Efficacy of a Catalytic Anti-Oligomeric Aβ42 scFv Antibody in Clearing Aβ42 Aggregates and Reducing Aβ Burden in the Brains of Alzheimer's Disease Mice.

Chuli Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.